Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Miriam Bertrand · SciRah

Researcher profile · Semantic Scholar

Miriam Bertrand

Share profile

Miriam Bertrand — researcher profile on SciRah

h-index: 9
Works: 18
Citations: 275

Most-cited papers

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients
D. Plenker, Miriam Bertrand, A. D. de Langen, R. Riedel +20 more
2017Clinical Cancer Research80 citations Open access
Semantic Scholar
Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens
Judith N. Müller, M. Falk, J. Talwar, N. Neemann +11 more
2017Journal of Thoracic Oncology52 citations Open access
Semantic Scholar
Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer
Sabine Jägle, Kerstin Rönsch, S. Timme, Hana Andrlová +10 more
2014Proceedings of the National Academy of Sciences of the United States of America36 citations Open access
Semantic Scholar
ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism
Alina Steinbach, Jan Winter, M. Reuschenbach, Renata Blatnik +6 more
2017Oncoimmunology26 citations Open access
Semantic Scholar
Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma.
O. Gautschi, R. Menon, Miriam Bertrand, C. Murer +1 more
2020Journal of Thoracic Oncology21 citations Open access
Semantic Scholar
Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants
N. Weisschuh, P. Mazzola, Miriam Bertrand, T. Haack +3 more
2021International Journal of Molecular Sciences16 citations Open access
Semantic Scholar
Secondary ROS1 mutations and lorlatinib sensitivity in crizotinib-refractory ROS1 positive NSCLC: Results of the prospective PFROST trial
L. Landi, M. Tiseo, L. Heukamp, R. Menon +15 more
2019Annals of Oncology11 citations Open access
Semantic Scholar
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer
F. Heitz, S. Lakis, P. Harter, S. Heikaus +17 more
2022PLoS ONE10 citations Open access
Semantic Scholar
Heterozygous pathogenic variants involving CBFB cause a new skeletal disorder resembling cleidocranial dysplasia
Tessi Beyltjens, E. Boudin, N. Revencu, N. Boeckx +17 more
2022Journal of Medical Genetics9 citations Open access
Semantic Scholar
Isolated cytokine‐enriched pericardial effusion: A likely key feature for Aymé‐Gripp syndrome
Anna-Lina König, H. Sabir, B. Strizek, U. Gembruch +8 more
2021American Journal of Medical Genetics. Part A7 citations Open access
Semantic Scholar
Identification and Characterization of a Novel Splice Site Mutation Associated with Glycogen Storage Disease Type VI in Two Unrelated Turkish Families
S. C. Grünert, L. Hannibal, A. Schumann, S. Rosenbaum-Fabian +5 more
2021Diagnostics3 citations Open access
Semantic Scholar
P1.14-03 Molecular Determinants for Lorlatinib Activity in ROS1 Positive NSCLC: Results of the Prospective PFROST Trial
L. Landi, M. Tiseo, L. Heukamp, R. Menon +15 more
2019Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
Impact of Somatic Mutations on Outcome in Patients > 60 Years Old with Newly Diagnosed AML Treated with Response-Adapted Sequential Azacitidine and Induction Chemotherapy within the DRKS00004519 Trial (RAS-AZIC) of the East German Study Group of Hematology and Oncology (OSHO)
Nadja Jaekel, Susann Schulze, U. Siebolts, A. Haak +12 more
2019Blood1 citations
Semantic Scholar
Concordance between comprehensive cancer genome profiling in plasma and matched tumor specimens.
R. Menon, Judith N. Müller, M. Falk, S. Lakis +10 more
20171 citations
Semantic Scholar
Cell-free tumor DNA in peri-operative blood samples from advanced high-grade serous ovarian cancer patients with and without complete resection.
F. Heitz, S. Lakis, P. Harter, J. Sehouli +16 more
20171 citations
Semantic Scholar
Liquid biopsy zur objektiven Beurteilung des post-operativen Tumorrestes bei Patientinnen mit fortgeschrittenem high-grade serösem Ovarialkarzinom
Alexandra Hengsbach, S. Lakis, F. Heitz, A. Talwar +15 more
2018Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
Abstract 1920: Targeting structural RET and MET kinase alterations in lung adenocarcinoma patients
D. Plenker, C. Lorenz, Miriam Bertrand, R. Riedel +7 more
2018Experimental and Molecular Therapeutics0 citations
Semantic Scholar
Detection of activating EGFR and KRAS mutations in a single liquid biopsy from a patient with adenocarcinoma of the lung using hybrid capture based sequencing
S. Lakis, J. Mueller, Miriam Bertrand, Johannes M. Heuckmann +5 more
2017Pneumologie0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Menon×11
Invite
R. Menon — researcher profile on SciRah
L. Heukamp×9
Invite
L. Heukamp — researcher profile on SciRah
J. Heuckmann×7
Invite
J. Heuckmann — researcher profile on SciRah
Judith N. Müller×6
Invite
Judith N. Müller — researcher profile on SciRah

×6

Invite

S. Lakis — researcher profile on SciRah

Invite

E. Mariotti — researcher profile on SciRah

Invite

F. Leenders — researcher profile on SciRah

F. Griesinger×3

Invite

F. Griesinger — researcher profile on SciRah

Invite

J. Talwar — researcher profile on SciRah

C. Gloeckner×3

Invite

C. Gloeckner — researcher profile on SciRah

Invite

T. Haack — researcher profile on SciRah

Invite

J. Sehouli — researcher profile on SciRah